These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3348473)

  • 1. Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers.
    Lange WR; Snyder FR; Lozovsky D; Kaistha V; Kaczaniuk MA; Jaffe JH
    Am J Public Health; 1988 Apr; 78(4):443-6. PubMed ID: 3348473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of HIV infection among intravenous drug users in the United States.
    Hahn RA; Onorato IM; Jones TS; Dougherty J
    JAMA; 1989 May; 261(18):2677-84. PubMed ID: 2651732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV seroprevalence in intravenous drug users: Los Angeles, California, 1986.
    Mascola L; Lieb L; Iwakoshi KA; McAllister D; Siminowski T; Giles M; Run G; Fannin SL; Strantz IH
    Am J Public Health; 1989 Jan; 79(1):81-2. PubMed ID: 2909190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection in Baltimore: antibody seroprevalence rates among parenteral drug abusers and prostitutes.
    Lange WR; Snyder FR; Lozovsky D; Kaistha V; Kaczaniuk MA; Jaffe JH
    Md Med J; 1987 Sep; 36(9):757-61. PubMed ID: 3683103
    [No Abstract]   [Full Text] [Related]  

  • 6. Human immunodeficiency virus seroprevalence and drug-using behavior in Milwaukee intravenous drug abusers.
    Belongia EA; Golubjatnikov R; McClellan-Tilson B; Wiesen RL; Vergeront JM; Davis JP
    J Acquir Immune Defic Syndr (1988); 1988; 1(4):381-5. PubMed ID: 3216319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug injecting and HIV infection among the population of drug abusers in Asia.
    Poshyachinda V
    Bull Narc; 1993; 45(1):77-90. PubMed ID: 8305908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection among drug abusers in the Belgrade area.
    Kilibarda M
    Bull Narc; 1993; 45(1):135-46. PubMed ID: 8305903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.
    Chaisson RE; Moss AR; Onishi R; Osmond D; Carlson JR
    Am J Public Health; 1987 Feb; 77(2):169-72. PubMed ID: 3467596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acquired immunodeficiency syndrome and intravenous drug abuse.
    Battjes RJ; Leukefeld CG; Pickens RW; Haverkos HW
    Bull Narc; 1988; 40(1):21-34. PubMed ID: 3064841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Constant annual incidence of HIV infection among intravenous drug addicts].
    Käll K; Olin R
    Lakartidningen; 1992 Sep; 89(36):2837-40. PubMed ID: 1405878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
    Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
    AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.
    Nelson KE; Galai N; Safaeian M; Strathdee SA; Celentano DD; Vlahov D
    Am J Epidemiol; 2002 Oct; 156(7):641-53. PubMed ID: 12244033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needle sharing among intravenous drug abusers: future directions.
    Battjes RJ; Pickens RW
    NIDA Res Monogr; 1988; 80():176-83. PubMed ID: 3136342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus seropositivity in intravenous drug users in Ohio.
    Seligman PJ; Campbell RJ; Keeler GP; Halpin TJ
    Ohio Med; 1989 Jan; 85(1):56-9. PubMed ID: 2927870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV seroprevalence in newborns in New York State.
    Novick LF; Berns D; Stricof R; Stevens R; Pass K; Wethers J
    JAMA; 1989 Mar 24-31; 261(12):1745-50. PubMed ID: 2918672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland.
    Vlahov D; Muñoz A; Anthony JC; Cohn S; Celentano DD; Nelson KE
    Am J Epidemiol; 1990 Nov; 132(5):847-56. PubMed ID: 2239899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral risk factors of human immunodeficiency virus infection among intravenous drug users and implications for preventive interventions.
    Nemoto T; Brown LS; Foster K; Chu A
    AIDS Educ Prev; 1990; 2(2):116-26. PubMed ID: 2393617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus and drug misuse: the Edinburgh experience.
    Brettle RP; Bisset K; Burns S; Davidson J; Davidson SJ; Gray JM; Inglis JM; Lees JS; Mok J
    Br Med J (Clin Res Ed); 1987 Aug; 295(6595):421-4. PubMed ID: 3115484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in condom behaviors and beliefs among female drug users recruited from two cities.
    Wood MM; Tortu S; Rhodes F; Deren S
    Women Health; 1998; 27(1-2):137-60. PubMed ID: 9640639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.